Hong Peng Wang
Sales & Marketing presso PEIJIA MEDICAL LIMITED
Profilo
Hong Peng Wang is currently the Marketing Director at Peijia Medical Technology (Suzhou) Co., Ltd.
and the Vice President-Marketing at Peijia Medical Ltd.
Prior to these roles, she held the position of Senior Manager-Marketing at Philips (China) Investment Co., Ltd.
from 2010 to 2018.
Before that, she worked as a Product Manager at Johnson & Johnson Medical (Shanghai) Ltd.
from 2007 to 2010.
Additionally, she served as a Marketing Manager at Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd.
from 2018 to 2019.
Ms. Wang completed her undergraduate degree at Shanghai Medical College of Fudan University in 2003 and obtained an MBA from Olin Business School in 2021.
Posizioni attive di Hong Peng Wang
Società | Posizione | Inizio |
---|---|---|
PEIJIA MEDICAL LIMITED | Sales & Marketing | 01/07/2019 |
Peijia Medical Technology (Suzhou) Co. Ltd.
Peijia Medical Technology (Suzhou) Co. Ltd. Medical SpecialtiesHealth Technology Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices. | Sales & Marketing | 01/07/2019 |
Precedenti posizioni note di Hong Peng Wang
Società | Posizione | Fine |
---|---|---|
Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd. | Sales & Marketing | 01/06/2019 |
Philips (China) Investment Co., Ltd.
Philips (China) Investment Co., Ltd. Electronics/AppliancesConsumer Durables Part of Koninklijke Philips NV, Philips (China) Investment Co. Ltd. is a Chinese company that manufactures consumer electronic products. The private company is based in Shanghai, China. The company was founded in 1990. Patrick S. Kung has been the CEO of the company since 2008. | Sales & Marketing | 01/12/2018 |
Johnson & Johnson Medical (Shanghai) Ltd.
Johnson & Johnson Medical (Shanghai) Ltd. Medical DistributorsDistribution Services Part of Johnson & Johnson, Johnson & Johnson Medical (Shanghai) Ltd. wholesales baby and beauty products. The private company is based in Shanghai, China. | Corporate Officer/Principal | 01/03/2010 |
Formazione di Hong Peng Wang
Olin Business School | Masters Business Admin |
Shanghai Medical College of Fudan University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PEIJIA MEDICAL LIMITED | Health Technology |
Aziende private | 4 |
---|---|
Philips (China) Investment Co., Ltd.
Philips (China) Investment Co., Ltd. Electronics/AppliancesConsumer Durables Part of Koninklijke Philips NV, Philips (China) Investment Co. Ltd. is a Chinese company that manufactures consumer electronic products. The private company is based in Shanghai, China. The company was founded in 1990. Patrick S. Kung has been the CEO of the company since 2008. | Consumer Durables |
Johnson & Johnson Medical (Shanghai) Ltd.
Johnson & Johnson Medical (Shanghai) Ltd. Medical DistributorsDistribution Services Part of Johnson & Johnson, Johnson & Johnson Medical (Shanghai) Ltd. wholesales baby and beauty products. The private company is based in Shanghai, China. | Distribution Services |
Peijia Medical Technology (Suzhou) Co. Ltd.
Peijia Medical Technology (Suzhou) Co. Ltd. Medical SpecialtiesHealth Technology Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices. | Health Technology |
Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd. |
- Borsa valori
- Insiders
- Hong Peng Wang